CONSUN PHARMAC.GR.HD -10 (C1P) — Capital Reinvestment Ratio
CONSUN PHARMAC.GR.HD -10 (C1P) has a Capital Reinvestment Ratio of 0.06x as of December 2025, meaning it reinvests 0% of its operating cash flow (€1.21 Billion) in capital expenditures (€68.48 Million). Check C1P goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CONSUN PHARMAC.GR.HD -10 Capital Reinvestment Ratio (2021–2025)
This chart tracks CONSUN PHARMAC.GR.HD -10's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see C1P cash generation efficiency.
Annual Capital Reinvestment Ratio for CONSUN PHARMAC.GR.HD -10 (2021–2025)
Year-by-year Capital Reinvestment Ratio for CONSUN PHARMAC.GR.HD -10 from 2021 to 2025. See C1P FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | €1.21 Billion | €68.48 Million | ▼ -43.6% |
| 2024 | 0.10x | €1.09 Billion | €109.00 Million | ▲ +56.2% |
| 2023 | 0.06x | €818.97 Million | €52.56 Million | ▲ +17.9% |
| 2022 | 0.05x | €947.68 Million | €51.59 Million | ▼ -59.8% |
| 2021 | 0.14x | €725.54 Million | €98.25 Million | — |